Sulfaguanidine

from Wikipedia, the free encyclopedia
Structural formula
Structural formula of sulfaguanidine
General
Non-proprietary name Sulfaguanidine
other names
  • 4-amino- N - (diaminomethylene) benzenesulfonamide
  • 4-amino- N - (diaminomethylene) benzenesulfonamide
  • 4-amino- N - (aminoiminomethyl) benzenesulfonamide
Molecular formula C 7 H 10 N 4 O 2 S
Brief description

White dust

External identifiers / databases
CAS number
  • 57-67-0
  • 6190-55-2 (monohydrate)
EC number 200-345-9
ECHA InfoCard 100,000,314
PubChem 5324
ChemSpider 5133
Wikidata Q414886
Drug information
ATC code

Q A07AB03

properties
Molar mass 214.24 g mol −1
Physical state

firmly

Melting point

190–193 ° C (monohydrate)

solubility
  • slightly soluble in water: 1 g l −1 (25 ° C)
  • slightly soluble in alcohol and acetone
  • insoluble in caustic soda
safety instructions
Please note the exemption from the labeling requirement for drugs, medical devices, cosmetics, food and animal feed
GHS labeling of hazardous substances
07 - Warning

Caution

H and P phrases H: 315-319-335
P: 261-305 + 351 + 338
As far as possible and customary, SI units are used. Unless otherwise noted, the data given apply to standard conditions .

Sulfaguanidine is a chemical compound belonging to the sulfonamide group .

properties

Sulfaguanidine is a white powder that gradually changes color in air.

use

Sulfaguanidine is used as a representative of the sulfonamides as an antibiotic in veterinary medicine (rarely). These compounds have an inhibitory effect on the intracellular folic acid synthesis of microorganisms and have a bacteriostatic effect after a latency period of 4 to 6 hours.

Pharmacological properties

Sulfaguanidine is one of the sulfonamides that are difficult to absorb orally and only has an effect on bacterial pathogens locally in the gastrointestinal tract .

Individual evidence

  1. a b c data sheet sulfaguanidines from Sigma-Aldrich , accessed on April 23, 2011 ( PDF ).
  2. a b c d e f Entry on sulfaguanidine at Vetpharm, accessed on July 29, 2012.
  3. ^ Hermann Hager, Franz von Bruchhausen: Hagers Handbook of Pharmaceutical Practice , Volume 5, p. 596; ISBN 978-3-540-62646-6 .